PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19501039-13 2009 The turnover of 15-PGDH was found to prolong in the presence of flurbiprofen as compared to that in the absence of this drug. Flurbiprofen 64-76 carbonyl reductase 1 Homo sapiens 16-23 21763448-6 2011 Flurbiprofen, indomethacin and other NSAIDs stimulated 15-PGDH activity in colon cancer HT29 cells as well as in lung cancer A549 cells and glioblastoma T98G cells. Flurbiprofen 0-12 carbonyl reductase 1 Homo sapiens 55-62 21763448-7 2011 (R)-flurbiprofen and sulindac sulfone, COX-2 inactive analogs, also stimulated 15-PGDH activity indicating induction of 15-PGDH is independent of COX-2 inhibition. Flurbiprofen 0-16 carbonyl reductase 1 Homo sapiens 79-86 21763448-7 2011 (R)-flurbiprofen and sulindac sulfone, COX-2 inactive analogs, also stimulated 15-PGDH activity indicating induction of 15-PGDH is independent of COX-2 inhibition. Flurbiprofen 0-16 carbonyl reductase 1 Homo sapiens 120-127 21763448-8 2011 Stimulation of 15-PGDH expression and activity by NSAIDs was examined in detail in colon cancer HT29 cells using flurbiprofen as a stimulant. Flurbiprofen 113-125 carbonyl reductase 1 Homo sapiens 15-22 21763448-9 2011 Flurbiprofen stimulated 15-PGDH expression and activity by increasing transcription and translation and by decreasing the turnover of 15-PGDH. Flurbiprofen 0-12 carbonyl reductase 1 Homo sapiens 24-31 21763448-9 2011 Flurbiprofen stimulated 15-PGDH expression and activity by increasing transcription and translation and by decreasing the turnover of 15-PGDH. Flurbiprofen 0-12 carbonyl reductase 1 Homo sapiens 134-141 21763448-12 2011 However, flurbiprofen down-regulated matrix metalloproteinase-9 (MMP-9) which was shown to degrade 15-PGDH, but up-regulated tissue inhibitor of metalloproteinase-1 (TIMP-1), an inhibitor of MMP-9 contributing further to a slower turnover of 15-PGDH. Flurbiprofen 9-21 carbonyl reductase 1 Homo sapiens 99-106 21763448-12 2011 However, flurbiprofen down-regulated matrix metalloproteinase-9 (MMP-9) which was shown to degrade 15-PGDH, but up-regulated tissue inhibitor of metalloproteinase-1 (TIMP-1), an inhibitor of MMP-9 contributing further to a slower turnover of 15-PGDH. Flurbiprofen 9-21 carbonyl reductase 1 Homo sapiens 242-249 19501039-0 2009 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. Flurbiprofen 67-79 carbonyl reductase 1 Homo sapiens 0-37 19501039-0 2009 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. Flurbiprofen 67-79 carbonyl reductase 1 Homo sapiens 39-46 19501039-4 2009 Flurbiprofen and several other NSAIDs were found to induce 15-PGDH expression in human colon cancer HT29 cells. Flurbiprofen 0-12 carbonyl reductase 1 Homo sapiens 59-66 19501039-5 2009 Flurbiprofen, the most active one, was also shown to induce 15-PGDH expression in other types of cancer cells. Flurbiprofen 0-12 carbonyl reductase 1 Homo sapiens 60-67 19501039-6 2009 Induction of 15-PGDH expression appeared to occur at the stage of mRNA as levels of 15-PGDH mRNA were increased by flurbiprofen in HT29 cells. Flurbiprofen 115-127 carbonyl reductase 1 Homo sapiens 13-20 19501039-6 2009 Induction of 15-PGDH expression appeared to occur at the stage of mRNA as levels of 15-PGDH mRNA were increased by flurbiprofen in HT29 cells. Flurbiprofen 115-127 carbonyl reductase 1 Homo sapiens 84-91 19501039-14 2009 Taken together, these results indicate that flurbiprofen up-regulates 15-PGDH by increasing the expression and decreasing the degradation of 15-PGDH in HT29 cells. Flurbiprofen 44-56 carbonyl reductase 1 Homo sapiens 70-77 19501039-14 2009 Taken together, these results indicate that flurbiprofen up-regulates 15-PGDH by increasing the expression and decreasing the degradation of 15-PGDH in HT29 cells. Flurbiprofen 44-56 carbonyl reductase 1 Homo sapiens 141-148